Paladino S, Conte A, Caggiano R, Pierantoni GM, Faraonio R
Common adverse effects are gastrointestinal and usually dose-related
IGF-1 LR3 achieves this by activating the insulin-like growth factor 1 receptors found in most human and animal cells
Researchers have found diseases including cardiovascular disease, non-alcoholic fatty liver disease, diabetic chronic kidney disease, osteoarthritis, autoimmune disease, alcohol use disorder and more could be positively impacted by GLP-1RA therapy
Some may experience minor swelling or bruising for 12 days
May Improve Fine Lines and Texture Several studies examining copper peptide-containing products have reported improvements in skin roughness, texture, and the appearance of fine lines